Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms

被引：0

作者：

Kohn G.E. ^{[1
]}

Kohn T.P. ^{[2
]}

Ramasamy R. ^{[3
]}

机构：

[1] Baylor University-Waco, 1301 S University Parks Dr, Waco, 76798, TX

[2] Baylor College of Medicine-Houston, 1 Baylor Plaza, Houston, 77030, TX

[3] Department of Urology, University of Miami, Miller School of Medicine, 1120 NW 14th Street, Room 1560, Miami, 33136, FL

来源：

Current Bladder Dysfunction Reports | 2017年 / 12卷 / 2期

关键词：

Benign prostatic hyperplasia; Hypogonadism; Lower urinary tract symptoms; Prostate; Testosterone;

D O I：

10.1007/s11884-017-0419-2

中图分类号：

学科分类号：

摘要：

Purpose of Review: While early studies suggested that testosterone replacement therapy would enlarge the prostate and worsen lower urinary tract symptoms, this review seeks to examine the combined evidence of observational studies, randomized control trials, and meta-analyses published on the topic to determine if testosterone replacement therapy worsens lower urinary tract symptoms in hypogonadal men. Recent Findings: The combined evidence of 15 randomized control trials and 2 meta-analyses has demonstrated emphatically that testosterone replacement therapy has no effect on lower urinary tract symptoms in hypogonadal men with mild and moderate symptoms. Summary: No randomized control trial has sufficiently examined the effect of testosterone replacement therapy in men with severe lower urinary tract symptoms. While a few observational studies have seen no effect when hypogonadal men with severe lower urinary tract symptoms are treated with testosterone replacement therapy, future randomized controlled trials specifically studying the effect of testosterone on men with severe lower urinary tract symptoms are warranted. In summary, clinicians should rest assured that testosterone does not worsen lower urinary tract symptoms in hypogonadal men with mild or moderate lower urinary tract symptoms. © 2017, Springer Science+Business Media New York.

引用

页码：118 / 123

页数：5

共 33 条

[1]

Behre H.M., Tammela T.L., Arver S., Tolra J.R., Bonifacio V., Lamche M., Et al., A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up, The aging male: the official journal of the International Society for the Study of the Aging Male, 15, 4, pp. 198-207, (2012)

[2]

Feldman H.A., Longcope C., Derby C.A., Johannes C.B., Araujo A.B., Coviello A.D., Et al., Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study, J Clin Endocrinol Metab, 87, 2, pp. 589-598, (2002)

[3]

Harman S.M., Metter E.J., Tobin J.D., Pearson J., Blackman M.R., Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging, J Clin Endocrinol Metab, 86, 2, pp. 724-731, (2001)

[4]

Dobs A.S., Meikle A.W., Arver S., Sanders S.W., Caramelli K.E., Mazer N.A., Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men, J Clin Endocrinol Metab, 84, 10, pp. 3469-3478, (1999)

[5]

Kenny A.M., Kleppinger A., Annis K., Rathier M., Browner B., Judge J.O., Et al., Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty, J Am Geriatr Soc, 58, 6, pp. 1134-1143, (2010)

[6]

Snyder P.J., Peachey H., Berlin J.A., Hannoush P., Haddad G., Dlewati A., Et al., Effects of testosterone replacement in hypogonadal men, J Clin Endocrinol Metab, 85, 8, pp. 2670-2677, (2000)

[7]

Wang C., Alexander G., Berman N., Salehian B., Davidson T., McDonald V., Et al., Testosterone replacement therapy improves mood in hypogonadal men—a clinical research center study, The Journal of Clinical Endocrinology & Metabolism., 81, 10, pp. 3578-3583, (1996)

[8]

Wang C., Swerdloff R.S., Iranmanesh A., Dobs A., Snyder P.J., Cunningham G., Et al., Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men 1, The Journal of Clinical Endocrinology & Metabolism, 85, 8, pp. 2839-2853, (2000)

[9]

Taylor B.C., Wilt T.J., Fink H.A., Lambert L.C., Marshall L.M., Hoffman A.R., Et al., Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study, Urology, 68, 4, pp. 804-809, (2006)

[10]

Jones C., Hill J., Chapple C., Management of lower urinary tract symptoms in men: summary of NICE guidance, BMJ (Clinical research ed), 340, (2010)

← 1 2 3 4 →